Reprieve Cardiovascular offers the Reprieve System, a personalized intelligent decongestion management solution that utilizes real-time patient data to optimize diuretic therapy for acute decompensated heart failure patients. This system addresses the challenge of fluid overload, which accounts for 83% of heart failure hospitalizations, by providing physicians with enhanced visibility and control over treatment decisions.
Funding
$47.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LVSVFounders
Product
Problem
Fluid overload is a primary driver of hospitalizations for acute decompensated heart failure (ADHF) patients, yet current diuretic-based treatments lack the precision needed to safely and effectively manage fluid removal. Physicians often lack real-time feedback on individual patient response, making it difficult to balance fluid removal with the risk of kidney injury.
Solution
Reprieve Cardiovascular offers the Reprieve System, a personalized intelligent decongestion management (IDM) solution designed for ADHF patients. The system leverages real-time patient data and a novel approach to diuretic management, providing physicians with enhanced visibility and control over therapy throughout treatment. By combining proven technology with continuous monitoring, the Reprieve System aims to safely accelerate fluid removal, optimizing diuretic therapy and potentially reducing hospital stays. The system provides care teams with the information needed to make efficient, data-driven treatment decisions.
Target Audience
The primary target audience includes physicians, care teams, and hospitals involved in the treatment of acute decompensated heart failure patients.
Features
- Real-time patient data integration for personalized diuretic management.
- Continuous monitoring of patient response to diuretic therapy.
- Intelligent algorithms to optimize fluid removal rates.
- Enhanced visibility and control of therapy for physicians and care teams.
- Aims to safely accelerate fluid removal compared to standard diuretic administration.